Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
On average, participants lost between 10% and 30% of their initial weight
Data were extracted from original study manuscripts and from reviews with detailed quantitative results of the pharmacokinetic endpoints of interest
When retatrutide becomes commercially available, switching from Ozempic will likely be possible under medical supervision
Curr Ther Res Clin Exp
Some people who experience side effects on one GLP-1 drug tolerate a different one better
US$ 26.45
US$ 20.78
US$ 25.56
US$ 22.16
US$ 25.78
